7Baggers
 Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know  sharewise.com Mon, 17 Nov 2025 19:13:47 GMT
 gain therapeutics reports continued progress amid financial challenges  The Globe and Mail Fri, 14 Nov 2025 04:56:40 GMT
 Gain Therapeutics reports Q3 EPS (15c), consensus (15c)  TipRanks Wed, 12 Nov 2025 13:02:39 GMT
 published on: 2025-11-10 01:16:01  newser.com Mon, 10 Nov 2025 07:16:01 GMT
 published on: 2025-11-09 13:16:36  newser.com Sun, 09 Nov 2025 19:16:36 GMT
 published on: 2025-11-09 04:58:47  newser.com Sun, 09 Nov 2025 10:58:47 GMT
 gain therapeutics to present at neuroscience 2025  The Manila Times Thu, 30 Oct 2025 11:21:15 GMT

Gain Therapeutics, Inc
(NASDAQ:GANX) 

GANX stock logo

Gain Therapeutics, Inc. is a redefining drug discovery company with its proprietary target identification platform. It focuses on identifying and optimizing allosteric binding sites and is unlocking new treatment options for disorders characterized by protein misfolding. The company was founded in 2...

Founded: 2017
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends